Skip to main content
Clinical Trials/NCT05532618
NCT05532618
Completed
Not Applicable

Efficacy of Adductor Canal Block for Anterior Cruciate Ligament Surgery: A Prospective Double Blinded Randomized Controlled Trial

St. Antonius Hospital1 site in 1 country34 target enrollmentAugust 1, 2022

Overview

Phase
Not Applicable
Intervention
Adductor canal block
Conditions
Anterior Cruciate Ligament Injuries
Sponsor
St. Antonius Hospital
Enrollment
34
Locations
1
Primary Endpoint
Postoperative pain level
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The goal of this study is to objectify the postoperative pain level, the use of opiates and postoperative nausea and vomiting after adding the adductor canal block to the standard pain regiment after anterior cruciate ligament surgery

Detailed Description

Patients scheduled for anterior cruciate ligament surgery will be randomized in an intervention and control group following informed consent. Before surgery, patients will receive an adductor canal bock with Levobupivacaine (intervention group) or 0.9% saline (control group). Following surgery, pain intensity, analgesic consumption and pain satisfaction will be recorded bij patients in a diary for 48 hours.

Registry
clinicaltrials.gov
Start Date
August 1, 2022
End Date
August 1, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Leon Timmerman

M.D., PhD, principal investigator

St. Antonius Hospital

Eligibility Criteria

Inclusion Criteria

  • Age 18 or older
  • Undergoing anterior cruciate ligament surgery under general anesthesia
  • ASA I-III

Exclusion Criteria

  • Contraindication for locoregional anesthesia; infection at the target puncture site, allergy to local anesthetics,
  • Neuromuscular disorders

Arms & Interventions

Levobupivacaine

Intervention group; 10 ml of Levobupivacaine 0.25% will be added in the adductor canal using ultrasound

Intervention: Adductor canal block

Levobupivacaine

Intervention group; 10 ml of Levobupivacaine 0.25% will be added in the adductor canal using ultrasound

Intervention: Levobupivacaine

Placebo

Control group; 10 ml of sodium chloride 0.9% will be added in the adductor canal using ultrasound

Intervention: Adductor canal block

Placebo

Control group; 10 ml of sodium chloride 0.9% will be added in the adductor canal using ultrasound

Intervention: Placebo

Outcomes

Primary Outcomes

Postoperative pain level

Time Frame: Within first 48 hours after surgery

Using Numerical Rating Scales for pain from 1 to 10, 1 is no pain, 10 is the worst pain you can imagine

Secondary Outcomes

  • Opiate use(Within first 48 hours after surgery)
  • Patient satisfaction(48 hours after surgery)
  • Nausea(Within first 48 hours after surgery)
  • Block result(within first 24 hours after surgery)

Study Sites (1)

Loading locations...

Similar Trials